5x broker valuation of 33c, page-81

Personally I'm a little surprised by the sell down. All the components are in place, we just need the company to light the fuse by dedicating a little time to spreading the story with the wider investment community. Bioshares was a start but when Chris was interim CEO he was certainly more active in getting in front of investors. Hopefully current management plan to continue with this, especially since the work load of finding new patients is now in the rear window. Might be worth investors suggesting such a plan to management if the levels of activity don't pick up?